OIG and CMS Clash on Medicare Overpayment Recoveries
OIG says the agency is leaving millions of dollars on the table, but CMS doesn’t want to hear it.
News
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Subscribe today for full access
to all of these articles.
Latest Articles
Eight Charged in Alleged $150M Crestar Labs Fraud Scheme
Individuals were supposedly paid kickbacks to obtain genetic samples for unnecessary genetic testing, which was then falsely billed to federal healthcare programs.
Most Lab Professionals Work in Understaffed Labs, Are Burnt Out
According to a recent survey of 1,112 respondents, despite modest salary increases, most medical lab professionals are struggling in understaffed labs.
MRI May Lower Breast Cancer Deaths from Variants in 3 Genes
Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50 percent among women who carry certain genetic changes in three genes, according to a comparative modeling analysis published Feb. 17, 2022, in JAMA Oncology. The...
Financing to Advance Early Autism Diagnosis and Treatment in Children
ATLANTA, GA — (BUSINESS WIRE) — EarliTec Dx, Inc. (“EarliTec”), a digital health company developing novel diagnostic and therapeutic products for children with autism spectrum disorder (ASD) and early childhood vulnerabilities, announced today a $19.5 million...
COVID-19 Testing Company in Hot Water for Numerous Infractions
An Illinois-based COVID-19 testing company and its laboratory is facing lawsuits from two different states as well as investigations from several state and federal authorities after patient and employee complaints brought to light a number of problems. The Center...
NIOSH Awards More than $5M to Address COVID-19 Related Challenges
The National Institute for Occupational Safety and Health (NIOSH) provided more than $5 million in extramural funding during fiscal year (FY) 2021 to 38 projects that address challenges related to the coronavirus disease 2019 (COVID-19) pandemic. This amount...
Whatever Happened to Those Part B Lab Test Spending Reductions?
The Protecting Access to Medicare Act (PAMA) was supposed to significantly reduce Medicare Part B lab tests spending. But it hasn’t happened. In FY 2018 and 2019, the first two years under the PAMA system, Medicare payments under the Clinical Laboratory Fee...
Genomenon Awarded NIH Grant to Curate the Human Genome
Ann Arbor, MI — February 15, 2022 — Genomenon, Inc., an AI-driven genomics company, today announced that it was awarded a $1.7 million grant by the National Institutes of Health (NIH) through the Small Business Innovation Research (SBIR) program. The grant is to...
Labcorp Enters Comprehensive, Long-Term Lab Relationship With Ascension
BURLINGTON, NC — (BUSINESS WIRE) — Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into agreements to create a comprehensive strategic relationship with Ascension, one of the nation’s leading Catholic and non-profit...
Ten Indicted for Health Care Kickbacks
Ten people, including two medical doctors, have been indicted in a $300 million health care fraud, announced U.S. Attorney for the Northern District of Texas Chad E. Meacham. The defendants—who stand accused of accused of conspiracy to commit health care fraud,...
Medicare Expands Coverage of LCDT Lung Cancer Screening
No cancer is more deadly than lung cancer. But early detection can save lives and head off costly and invasive treatment. With this in mind, the Centers for Medicare and Medicaid Services (CMS) issued a national coverage determination (NCD) expanding coverage for...
New Assay Could ID Best Cancer Treatment Earlier and Faster
A recently developed assay could make identifying the best cancer treatment for each patient a quicker and more cost-effective process, compared to current tests. Researchers from the Public Health Research Institute of the New Jersey Medical School of Rutgers...
